Abiomed (ABMD) Surpasses 15,000 Impella Patients in the United States
8/2/2013 9:26:41 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
DANVERS, Mass., Aug. 2, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported that physicians have implanted more than 15,000 Impella® pumps in U.S. patients requiring hemodynamic support. The 15,000th Impella procedure took place at Mercy General Hospital in Sacramento, California with an Impella pump that provided prophylactic circulatory support.
Help employers find you! Check out all the jobs and post your resume.
comments powered by